Internal Medicine, Rheumatology · Charleston, SC
NPI
1043392392
Since 2006
Specialty
Internal Medicine, Rheumatology
Code 207RR0500X
Group practices
1
Medicare group memberships
Hospitals
4
Hospital affiliations
96 Jonathan Lucas St, Suite 912 Csb
Charleston, SC, 29425
Phone (843) 792-3484
Groups this clinician bills Medicare through
Medicare paid, 2024
$103K
3,647 services
Medicare patients, 2024
402
Average age 73
Drug cost, 2024
$3.3M
1,349 prescriptions
Company payments, 2025
$347
From 4 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Faye N Hant was code G2211 (visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's), 292 times for 195 patients. In total Faye N Hant billed 3,647 services in 43 codes, and Medicare paid $103K.
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2007-07-08.
| Code | Setting | Services | Patients | Paid per service | Medicare paid |
|---|---|---|---|---|---|
| G2211 Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's | Facility | 292 | 195 | $11.55 | $3,371 |
| G2211 Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's | Office | 251 | 177 | $11.49 | $2,883 |
| 99214 Office E&M - Established | Office | 209 | 154 | $83.61 | $17K |
| 99214 Office E&M - Established | Facility | 201 | 150 | $62.75 | $13K |
| 99215 Office E&M - Established | Facility | 73 | 50 | $104.28 | $7,613 |
| 99215 Office E&M - Established | Office | 30 | 26 | $111.75 | $3,352 |
| 99213 Office E&M - Established | Office | 21 | 21 | $58.07 | $1,220 |
| 99204 Office E&M - New | Facility | 17 | 17 | $97.78 | $1,662 |
| 99213 Office E&M - Established | Facility | 16 | 15 | $43.12 | $690 |
| 99205 Office E&M - New | Facility | 14 | 14 | $126.09 | $1,765 |
By year: 2022 $55K for 728 services; 2023 $57K for 2,274 services; 2024 $103K for 3,647 services.
Medicare prescription drug claims, 2024
In 2024, the drug Faye N Hant prescribed most often to Medicare patients was Hydroxychloroquine Sulfate, with 160 prescriptions and refills. In total Faye N Hant wrote 1,349 Medicare prescriptions that cost $3.3M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Hydroxychloroquine Sulfate Generic | 160 | 405 | 49 | $7,273 |
| Methotrexate Methotrexate Sodium | 129 | 222 | 29 | $2,881 |
| Prednisone Generic | 82 | 175 | 34 | $527 |
| Alendronate Sodium Generic | 70 | 168 | 20 | $786 |
| Humira(Cf) Pen Adalimumab | 61 | 64 | Under 11 | $594K |
| Forteo Teriparatide | 54 | 60 | 11 | $224K |
| Mycophenolate Mofetil Generic | 49 | 106 | 15 | $5,964 |
| Humira Pen Adalimumab | 43 | 50 | Under 11 | $486K |
| Enbrel Sureclick Etanercept | 33 | 63 | Under 11 | $440K |
| Methotrexate Sodium Methotrexate Sodium/Pf | 32 | 34 | Under 11 | $221 |
| Rasuvo Methotrexate/Pf | 26 | 33 | Under 11 | $18K |
| Orencia Clickject Abatacept | 25 | 31 | Under 11 | $173K |
| Celecoxib Generic | 23 | 49 | Under 11 | $332 |
| Diclofenac Sodium Generic | 19 | 27 | Under 11 | $620 |
| Allopurinol Generic | 19 | 50 | Under 11 | $414 |
Brand drugs: 479 claims; generic drugs: 827 claims; opioid claims: 21.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Faye N Hant $347 ($347 in general payments such as food, travel and fees) from 4 companies. The largest payer was Abbvie Inc. with $199.
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.